IL6 and congenital rubella syndrome: Results from animal studies reported in May 2018 implicate recipient monocyte-derived and/or macrophage-derived IL-1, IL-6, and nitric oxide (and not CAR T cell-derived cytokines) as the key determinants of the severity of CRS and CRES34,35.